☆ 4.7 Article

GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8

Xiao-tian Chang et al.

Summary: The study found that PADI4 expression is upregulated in gastric cancer and overexpression of PADI4 can increase the proliferation, migration, metastasis, and tumorigenic ability of GC cells, while reducing apoptosis ability. By promoting IL-8 expression, PADI4 accelerates the metastatic capacity of gastric cancer cells.

BMC GASTROENTEROLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia

Jawed Akhtar Siddiqui et al.

Summary: Growth differentiation factor 15 or macrophage inhibitory cytokine-1 (GDF15/MIC-1) is a divergent member of the transforming growth factor beta superfamily and has diverse pathophysiological roles in cancers, cardiometabolic disorders, and other diseases. Its role in cancer development and progression is complicated and depends on the specific cancer type and stage, and its mechanisms are related to its receptor GFRAL.

CYTOKINE & GROWTH FACTOR REVIEWS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Kurarinone induced p53-independent G0/G1 cell cycle arrest by degradation of K-RAS via WDR76 in human colorectal cancer cells

Mincheol Kwon et al.

Summary: Kurarinone (KR), a flavonoid in Sophora flavescens, can inhibit the proliferation of colorectal cancer cells by reducing the protein level of K-RAS, leading to G0/G1 cell cycle arrest. It has potential anti-tumor activity regardless of the p53 status.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Add to Collection

Review Cell Biology

Cell cycle on the crossroad of tumorigenesis and cancer therapy

Jing Liu et al.

Summary: Cell cycle aberrancy is a fundamental mechanism underlying tumorigenesis, and therapies targeting cell cycle machinery components can not only suppress cancer cell division but also reverse cancer metabolism and restore cancer immune surveillance. Recently, proteolysis targeting chimeras (PROTACs) have been used to target oncogenic proteins related to cell cycle progression for more effective tumor suppression.

TRENDS IN CELL BIOLOGY (2022)

Add to Collection

Article Oncology

Recent Estimates and Predictions of 5-Year Survival in Patients with Gastric Cancer: A Model-Based Period Analysis

Yunmei Li et al.

Summary: This study analyzed the survival rates and trends of gastric cancer patients in the United States, finding overall improvement but still low survival rates. There were differences in survival rates among different subgroups, with particularly low rates for patients with advanced-stage gastric cancer.

CANCER CONTROL (2022)

Add to Collection

Article Cell & Tissue Engineering

GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation

Jawed Akhtar Siddiqui et al.

Summary: This study suggests that growth differentiation factor-15 (GDF15) plays a critical role in the modulation of bone microenvironment by prostate cancer (PCa). GDF15 promotes bone metastases and facilitates PCa growth in bone by activating osteoblasts and recruiting osteomacs.

BONE RESEARCH (2022)

Add to Collection

Review Oncology

Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways

Milad Ashrafizadeh et al.

Summary: Despite advancements in diagnostic tools and anti-tumor drugs, the survival time of gastric cancer patients has not significantly increased. Studies have shown that signaling pathways such as Wnt, Nrf2, MAPK, and PI3K/Akt are involved in GC invasion, with long non-coding RNAs and microRNAs playing a role in GC malignancy. Resveratrol exhibits high anti-tumor activity and has the potential to target various signaling pathways to induce apoptotic cell death and inhibit migration and metastasis of GC cells.

CANCER CELL INTERNATIONAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc

Sarah K. Madden et al.

Summary: Direct inhibition of c-Myc, a transcription factor overexpressed in many human cancers, has shown promising results in triggering tumor regression with reversible side effects. Challenges and lessons from current inhibitors are evaluated to explore future strategies for translating c-Myc inhibitors into clinical practice, such as miniaturisation of Omomyc and targeting E-box binding.

MOLECULAR CANCER (2021)

Add to Collection

Article Endocrinology & Metabolism

Growth Differentiation Factor 15 Is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for Invasiveness

Yea Eun Kang et al.

Summary: The study revealed that mitochondrial stress induces the expression of GDF15 in thyroid cancer cells, and GDF15 promotes tumor invasion by activating STAT3. Therefore, the GDF15-STAT3 signaling axis may serve as a potential therapeutic target for thyroid cancer aggressiveness.

THYROID (2021)

Add to Collection

Article Biochemistry & Molecular Biology

STAT3 plays an important role in DNA replication by turning on WDHD1

Yunying Zhou et al.

Summary: STAT3 plays an important role in DNA replication, mediated by its newly identified target gene WDHD1. These studies have significant implications.

CELL AND BIOSCIENCE (2021)

Add to Collection

Article Cell Biology

GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1/2-c-Fos-LIF signaling

Shan Zhu et al.

Summary: The study showed that GDF15 promotes the GSC-like phenotype in GSCLCs by activating the LIF-STAT3 signaling pathway, which is dependent on the ERK1/2 signaling pathway. The small immunomodulator imiquimod can induce GDF15 expression and promote the development of the GSC-like phenotype.

CELL DEATH DISCOVERY (2021)

Add to Collection

Review Cell Biology

The Role of GDF15 as a Myomitokine

Kornelia Johann et al.

Summary: Growth differentiation factor 15 (GDF15) is a cytokine that affects systemic energy metabolism and its expression and secretion in various organs and tissues are induced in different physiological and pathophysiological states, often associated with mitochondrial stress. GDF15 is considered as a myokine and cardiokine, and activation of the GDF15-GFRAL pathway may lead to increased sympathetic outflow and activation of the HPA stress axis.

CELLS (2021)

Add to Collection

Review Immunology

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

Joerg Wischhusen et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death

S. Busker et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Oncology

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

Daisy I. Izaguirre et al.

CANCERS (2020)

Add to Collection

Review Pharmacology & Pharmacy

Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases

Seung Joon Baek et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Multidisciplinary Sciences

Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells

Maria Kalli et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis

Jie-yu Liu et al.

FEBS OPEN BIO (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Highlighted STAT3 as a potential drug target for cancer therapy

Haeri Lee et al.

BMB REPORTS (2019)

Add to Collection

Article Oncology

GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2

Shan Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Add to Collection

Review Oncology

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15

Gang Dong et al.

CANCER MEDICINE (2018)

Add to Collection

Review Physiology

GDF15 and Growth Control

Paul J. Emmerson et al.

FRONTIERS IN PHYSIOLOGY (2018)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Do STAT3 inhibitors have potential in the future for cancer therapy?

Andrea L. A. Wong et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)

Add to Collection

Editorial Material Cell Biology

Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition

Bernd Groner et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)

Add to Collection

Article Oncology

Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer

Xiaobing Wang et al.

ONCOTARGET (2017)

Add to Collection

Article Biochemistry & Molecular Biology

JAK-STAT signaling in cancer: From cytokines to non-coding genome

Jan Pencik et al.

CYTOKINE (2016)

Add to Collection

Review Immunology

Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression

Peter J. Chockley et al.

JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Myc and cell cycle control

Gabriel Bretones et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)

Add to Collection

Article Oncology

The Diffusion of Docetaxel in Patients With Metastatic Prostate Cancer

Joseph M. Unger et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Add to Collection

Review Oncology

Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention

Parisa Karimi et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

Add to Collection

Review Gastroenterology & Hepatology

Genetics of gastric cancer

Main I. H. McLean et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Add to Collection

Review Oncology

Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study

Norihisa Saeki et al.

CANCER SCIENCE (2013)

Add to Collection

Article Pharmacology & Pharmacy

Tumour selective targeting of cell cycle kinases for cancer treatment

Marieke Aarts et al.

CURRENT OPINION IN PHARMACOLOGY (2013)

Add to Collection

Review Cell Biology

Control of cell cycle transcription during G1 and S phases

Cosetta Bertoli et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)

Add to Collection

Article Oncology

c-Myc and Cancer Metabolism

Donald M. Miller et al.

CLINICAL CANCER RESEARCH (2012)

Add to Collection

Article Oncology

Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies

Pasquale Sansone et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Add to Collection

Article Oncology

Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis

Wei Kang et al.

CLINICAL CANCER RESEARCH (2011)

Add to Collection

Article Oncology

GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas

Patrick Roth et al.

CLINICAL CANCER RESEARCH (2010)

Add to Collection

Article Oncology

Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer

Anne Cathrine Staff et al.

GYNECOLOGIC ONCOLOGY (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Activation of STAT3 by specific G alpha subunits and multiple G beta gamma dimers

Jessie W. F. Yuen et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)

Add to Collection

Review Cell Biology

Divergent Molecular Mechanisms Underlying the Pleiotropic Functions of Macrophage Inhibitory Cytokine-1 in Cancer

Murielle Mimeault et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2010)

Add to Collection

Article Oncology

gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

Julia Bollrath et al.

CANCER CELL (2009)

Add to Collection

Review Cell Biology

STAT3 as a target for inducing apoptosis in solid and hematological tumors

Khandaker Al Zaid Siddiquee et al.

CELL RESEARCH (2008)

Add to Collection

Article Multidisciplinary Sciences

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

JB Welsh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Add to Collection

Article Biochemistry & Molecular Biology

Roles of STAT3 defined by tissue-specific gene targeting

S Akira

ONCOGENE (2000)

Add to Collection

Article Gastroenterology & Hepatology

Analysis of 154 actual five-year survivors of gastric cancer

SN Hochwald et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.